Skip to main content
Independent federal grant matching. Not affiliated with any government agency. Get free access and see which open grants fit your organization.
Closed on May 15, 2026

Make America Healthy Again – Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence

Center for Medicare and Medicaid Services · Opportunity number CMS-2W2-27-001

Details summarized from the official notice as of May 16, 2026. Always confirm eligibility, deadlines and requirements in the official notice before applying.

Independent platform. Not affiliated with or endorsed by any government agency. Data from public federal sources.

This opportunity is closed as of May 15, 2026. It is kept here for reference. See the related open opportunities below, or check the official listing in case the agency posts a new cycle.

Key facts

Opportunity numberCMS-2W2-27-001
AgencyCenter for Medicare and Medicaid Services
Department of Health and Human Services
Assistance listing (ALN, formerly CFDA)93.460
PostedMar 13, 2026
DeadlineMay 15, 2026
Award ceiling$3,300,000
Expected number of awards15
Estimated total program funding$100,000,000
Cost sharing or matching requiredNo
Funding typeCooperative agreement
CategoryHealth
Last updated hereMay 16, 2026

Summary from the notice

The Centers for Medicare & Medicaid Services (CMS), through its Centers for Medicare and Medicaid Innovation (CMMI or Innovation Center), is soliciting applications for the Make America Healthy Again: Enhancing Lifestyle & Evaluating Value-based Approaches Through Evidence (MAHA ELEVATE) Model. This voluntary, three-year service delivery model is designed to test evidence-based, whole-person functional or lifestyle medicine (“whole-person FLM”) approaches to care. Rather than treating diseases separately after they develop, MAHA ELEVATE takes a proactive, comprehensive approach that combines psychological, nutritional, and physical interventions with personalized, lifestyle-based strategies for prevention and early treatment. 


Throughout this NOFO, we use the term “whole-person FLM” to represent a range of services or approaches often incorporated in lifestyle and functional medicine that are not currently covered under Medicare. It is important to clarify that CMS is not establishing a new industry standard through the use of this terminology. The term “whole-person FLM” as used in this NOFO does not represent an attempt by CMS to create, define, or establish any new industry-wide standard, practice guideline(s), or healthcare delivery model beyond the scope of this specific Innovation Center model and funding opportunity. Similarly, through this funding opportunity, CMS is not creating a new category of covered services for Medicare purposes. This term serves solely as a descriptive reference within this document to facilitate clear communication about the non-covered services being tested in this model and should not be interpreted as having any regulatory, coverage, or policy implications beyond the context of this specific Innovation Center model.


CMS will select a total of up to 30 Recipients to participate in MAHA ELEVATE. The model will be split into two cohorts, one year apart (years 2026 and 2027). 


CMS will select recipients based on five key criteria: 

• Whole-person FLM intervention design, including cost savings. 

• Beneficiary recruitment and study design. 

• Organizational and administrative capacity. 

• Data management capabilities. 

• Budget. 

Highly competitive applicants must demonstrate several important strengths: 

• Strong, evidence-based support for your proposed intervention(s) and 

proof of your own successful history of implementation of the 

intervention and cost savings. 

• Ability to recruit large numbers of participants with a clear randomization 

plan and advanced data management capabilities. 


Given the model’s minimum beneficiary targets and extensive data management requirements, applicants who do not directly provide clinical care are strongly encouraged to form partnerships with care entities or organizations that deliver clinical care. This collaboration helps ensure you can meet the full operational requirements of the program. 

Who can apply

The official notice lists these applicant types as eligible:

  • Unrestricted (open to any type of entity, check the notice)

Eligibility details from the notice

Eligible applicants include any organization that meets the requirements outlined in this NOFO. Individuals are not eligible to apply. Examples of eligible applicants may include, but are not limited to: • Private medical practices. • Health systems and Accountable Care Organizations (ACOs). • Academic organizations. • Functional, lifestyle, preventive, and integrative medicine centers. • Community-based organizations (CBOs). • Federally Qualified Health Centers (FQHCs). • Rural Health Clinics (RHCs). • Indian Health Service/Tribal Services/Urban Indian Programs (ITUs). • Local and state governments. Organizations spanning multiple states are eligible to apply.

Registrations you will likely need

Most applications submitted through Grants.gov need the following. Registration can take several weeks, so start early. The notice lists the exact requirements.

Related open opportunities

Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)

National Institutes of Health · PAR-25-155

Deadline: Oct 19, 2026 (3 days left) Up to: $50,000 Health

Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

National Institutes of Health · RFA-CA-27-021

Deadline: Oct 19, 2026 (3 days left) Up to: $600,000 Health